EHRA / EAPCI expert consensus statement on catheter-based left atrial appendage occlusion

Cardiology, Bern University Hospital, 3010 Bern, Switzerland; Department of Cardiology, Maastricht University Medical Center, 6281 Maastricht, The Netherlands; Isar Medical Centre, 80331 Munich, Germany; Cardiovascular Center Frankfurt, 60389 Frankfurt, Germany; Cardiac Arrhythmia Research Center, Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy; and Davidai Arrhythmia Center, Sheba Medical Center, 52621 Tel Hashomer, Israel

[1]  K. Minematsu,et al.  Blood Flow in the Left Atrial Appendage and Embolic Stroke in Nonvalvular Atrial Fibrillation , 2001, European Neurology.

[2]  T. Şahin,et al.  Evaluation of Left Atrial Appendage Functions According to Different Etiologies of Atrial Fibrillation with a Tissue Doppler Imaging Technique by Using Transesophageal Echocardiography , 2009, Echocardiography.

[3]  P. Kirchhof,et al.  Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF) , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  Frederick T. Han,et al.  Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. , 2013, Journal of the American College of Cardiology.

[5]  M. Lesh,et al.  Percutaneous Left Atrial Appendage Transcatheter Occlusion to Prevent Stroke in High-Risk Patients With Atrial Fibrillation: Early Clinical Experience , 2002, Circulation.

[6]  G. Breithardt,et al.  Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  Byoung Wook Choi,et al.  Thrombus in the left atrial appendage in stroke patients: detection with cardiac CT angiography--a preliminary report. , 2008, Radiology.

[8]  E. Lonn,et al.  Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. , 2005, American heart journal.

[9]  B. Lüderitz,et al.  Fate of left atrial thrombi in patients with atrial fibrillation determined by transesophageal echocardiography and cerebral magnetic resonance imaging. , 2004, The American journal of cardiology.

[10]  W. Manning,et al.  Accuracy of Transesophageal Echocardiography for Identifying Left Atrial Thrombi: A Prospective, Intraoperative Study , 1995, Annals of Internal Medicine.

[11]  S. Kahn,et al.  Nonvalvular atrial fibrillation: evidence for a prothrombotic state. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[12]  K. Okumura,et al.  Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism. , 2004, Chest.

[13]  W. Manning,et al.  Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. , 1995, Circulation.

[14]  P. Wenaweser,et al.  Amplatzer left atrial appendage occlusion: Single center 10‐year experience , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[15]  M. Russo,et al.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[16]  P. Wenaweser,et al.  Percutaneous left atrial appendage closure , 2012 .

[17]  Donald R. Lynch.  Apixaban in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[18]  Bertil Olsson,et al.  Outcome parameters for trials in atrial fibrillation: executive summary. , 2007, European heart journal.

[19]  P. Wenaweser,et al.  Ad hoc percutaneous left atrial appendage closure. , 2013, The Journal of invasive cardiology.

[20]  G Hindricks,et al.  Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease , 2004, Heart.

[21]  Ê. Guérios,et al.  Oclusão do apêndice atrial esquerdo com o Amplatzer Cardiac Plug em pacientes com fibrilação atrial , 2012 .

[22]  A. Camm,et al.  An update and current expert opinions on percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[23]  G. Naccarelli,et al.  Increasing prevalence of atrial fibrillation and flutter in the United States. , 2009, The American journal of cardiology.

[24]  D. Packer,et al.  Left Atrial Appendage Obliteration in Atrial Fibrillation Thoracoscopic Extracardiac Obliteration of the Left Atrial Appendage for Stroke Risk Reduction in Atrial Fibrillation , 2003 .

[25]  G. Lip,et al.  Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm , 2012, Thrombosis and Haemostasis.

[26]  J. Halperin,et al.  Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. , 2001, The New England journal of medicine.

[27]  G. Raskob,et al.  Hemorrhagic complications of anticoagulant treatment. , 1992, Chest.

[28]  A. Camm,et al.  Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[29]  T. Zapolski,et al.  Transcatheter left atrial appendage occlusion in patients with atrial fibrillation , 2015 .

[30]  R. de Caterina,et al.  Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W) , 2008, Stroke.

[31]  R. Nieuwlaat.  Management of atrial fibrillation in Europe , 2007 .

[32]  A. Hobbs,et al.  Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. , 2016, International journal of cardiology.

[33]  Zhao-qi Zhang,et al.  Comparison of contrast enhanced 64-slice computed tomography and transesophageal echocardiography in detection of left atrial thrombus in patients with atrial fibrillation , 2008, Journal of Interventional Cardiac Electrophysiology.

[34]  C. Pollick,et al.  Assessment of Left Atrial Appendage Function by Transesophageal Echocardiography: Implications for the Development of Thrombus , 1991, Circulation.

[35]  L. Tsai,et al.  Role of transesophageal echocardiography in detecting left atrial thrombus and spontaneous echo contrast in patients with mitral valve disease or non-rheumatic atrial fibrillation. , 1990, Journal of the Formosan Medical Association = Taiwan yi zhi.

[36]  E. Blackstone,et al.  Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. , 2008, Journal of the American College of Cardiology.

[37]  H. Wijeysundera,et al.  Economic Evaluation of Percutaneous Left Atrial Appendage Occlusion, Dabigatran, and Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation , 2013, Circulation.

[38]  G. Breithardt,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[39]  S. Yakubov,et al.  Catheter-Based Left Atrial Appendage (LAA) Ligation for the Prevention of Embolic Events Arising From the LAA: Initial Experience in a Canine Model , 2010, Circulation. Cardiovascular interventions.

[40]  G. Schuler,et al.  STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: LONG-TERM RESULTS AFTER 6 YEARS OF THE WATCHMAN LEFT ATRIAL APPENDAGE OCCLUSION PILOT STUDY , 2011 .

[41]  Mårten Rosenqvist,et al.  Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. , 2012, European heart journal.

[42]  Gregory Y H Lip,et al.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.

[43]  I. Kubota,et al.  Prognostic value of low left atrial appendage wall velocity in patients with ischemic stroke and atrial fibrillation. , 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[44]  P. Lambiase,et al.  Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory? , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[45]  Gerhard Hindricks,et al.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[46]  J. Bermejo,et al.  Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. , 2003, Journal of the American College of Cardiology.

[47]  Ming Zhang,et al.  Percutaneous catheter-based left atrial appendage ligation and management of periprocedural left atrial appendage perforation with the LARIAT suture delivery system. , 2012, The Journal of invasive cardiology.

[48]  Leon Poller,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[49]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[50]  N. Ammash,et al.  Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. , 1995, Journal of the American College of Cardiology.

[51]  I. Cruz-González,et al.  Thrombus formation after left atrial appendage exclusion using an amplatzer cardiac plug device , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[52]  R B D'Agostino,et al.  Stroke severity in atrial fibrillation. The Framingham Study. , 1996, Stroke.

[53]  Kôki Nakamura,et al.  Transesophageal echocardiography for thrombus screening prior to left atrial catheter ablation. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[54]  A. d'Avila,et al.  A New Technique to Perform Epicardial Mapping in the Electrophysiology Laboratory , 1996, Journal of cardiovascular electrophysiology.

[55]  J. McMurray,et al.  Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study , 2001, Heart.

[56]  G. Lip,et al.  Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe , 2011, Thrombosis and Haemostasis.

[57]  F. McAlister,et al.  Why do patients with atrial fibrillation not receive warfarin? , 2000, Archives of internal medicine.

[58]  E. Heist,et al.  Analysis of the left atrial appendage morphology by intracardiac echocardiography in patients with atrial fibrillation , 2011, Journal of Interventional Cardiac Electrophysiology.

[59]  J. Koziol,et al.  Comparison of Magnetic Resonance Imaging and Transesophageal Echocardiography in Detection of Thrombus in the Left Atrial Appendage , 2003, Stroke.

[60]  A. Martinez-Naharro,et al.  Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with the Amplatzer cardiac plug. , 2013, Revista espanola de cardiologia.

[61]  J. Tolstrup,et al.  Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study , 2011, Thrombosis and Haemostasis.

[62]  R. Landymore,et al.  Staple closure of the left atrial appendage. , 1984, Canadian journal of surgery. Journal canadien de chirurgie.

[63]  G. Schuler,et al.  Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. , 2007, Journal of the American College of Cardiology.

[64]  J. Madden.  Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli. , 1949, Journal of the American Medical Association.

[65]  X. Freixa,et al.  The Amplatzer™ Cardiac Plug 2 for left atrial appendage occlusion: novel features and first-in-man experience. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[66]  J. Odell,et al.  Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. , 1996, The Annals of thoracic surgery.

[67]  J. Halperin,et al.  Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. , 1998, Journal of the American College of Cardiology.

[68]  P. Teirstein,et al.  Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. , 2009, JACC. Cardiovascular interventions.

[69]  G. Lip,et al.  Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[70]  S. Yakubov,et al.  Feasibility of closed-chest ligation of the left atrial appendage in humans. , 2011, Heart rhythm.

[71]  P. Neužil,et al.  PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[72]  C. Stone,et al.  The left atrial appendage: our most lethal human attachment! Surgical implications. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[73]  H. Sievert,et al.  Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. , 2004, Journal of the American College of Cardiology.

[74]  J. Saw,et al.  Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. , 2013, Journal of the American College of Cardiology.

[75]  B. Leithäuser,et al.  Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes. , 2009, The Journal of invasive cardiology.

[76]  G. Lip,et al.  Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study. , 2000, American heart journal.

[77]  J. Dunning,et al.  Best evidence topic - Cardiac general Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion? , 2010 .

[78]  Angelo Auricchio,et al.  Evaluation of the Left Atrial Appendage With Real-Time 3-Dimensional Transesophageal Echocardiography: Implications for Catheter-Based Left Atrial Appendage Closure , 2011, Circulation. Cardiovascular imaging.

[79]  S. Yusuf,et al.  Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial , 2011, Circulation.

[80]  Martha J. Radford,et al.  Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .

[81]  L. Tsai,et al.  Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation. , 1997, International journal of cardiology.

[82]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[83]  R. Cury,et al.  Multidetector Computed Tomography for the Detection of Left Atrial Appendage Thrombus: A Comparative Study With Transesophageal Echocardiography , 2007, Journal of computer assisted tomography.

[84]  B. Lindsay,et al.  Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. , 2009, Journal of the American College of Cardiology.

[85]  Jay Brown,et al.  Left atrial thrombi in non-rheumatic atrial fibrillation: assessment of prevalence by transesophageal echocardiography , 1993, The International Journal of Cardiac Imaging.

[86]  Massimo Santini,et al.  Trans-septal catheterization in the electrophysiology laboratory: data from a multicenter survey spanning 12 years. , 2006, Journal of the American College of Cardiology.

[87]  Saibal Kar,et al.  Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry , 2011, Circulation.

[88]  M. Post,et al.  Ablation for Atrial Fibrillation in Combination With Left Atrial Appendage Closure: First Results of a Feasibility Study , 2012, Journal of the American Heart Association.

[89]  P. Wenaweser,et al.  Left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation. , 2012, Arquivos brasileiros de cardiologia.

[90]  W. Daniel,et al.  Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. , 1994, Journal of the American College of Cardiology.

[91]  V. Gudnason,et al.  Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[92]  Deepak L. Bhatt,et al.  Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting , 2011, Thrombosis and Haemostasis.

[93]  D. Schwartzman,et al.  Dynamic multidimensional imaging of the human left atrial appendage. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[94]  Rita A. Longaker,et al.  Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. , 2003, American heart journal.

[95]  Mario J. Garcia,et al.  Left atrial appendage filling defects identified by multidetector computed tomography in patients undergoing radiofrequency pulmonary vein antral isolation: a comparison with transesophageal echocardiography. , 2007, American heart journal.

[96]  R. Becker,et al.  Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. , 2005, Journal of the American College of Cardiology.

[97]  P. Kirchhof,et al.  A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[98]  M. Buchbinder,et al.  QUALITY OF LIFE ASSESSMENT IN THE RANDOMIZED PROTECT AF TRIAL OF PATIENTS AT RISK FOR STROKE WITH NON-VALVULAR ATRIAL FIBRILLATION , 2012 .

[99]  B. Yan,et al.  Left atrial appendage closure with Amplatzer cardiac plug for stroke prevention in atrial fibrillation: Initial Asia‐Pacific experience , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[100]  A. Rabinstein.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2010 .

[101]  I. Kronzon,et al.  Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. , 2000, Journal of the American College of Cardiology.

[102]  A. Hofman,et al.  Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. , 2006, European heart journal.

[103]  Timothy Watson,et al.  Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited , 2009, The Lancet.

[104]  Bernhard Meier,et al.  Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. , 2005, Journal of the American College of Cardiology.

[105]  Sanghamitra Mohanty,et al.  Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. , 2012, Journal of the American College of Cardiology.

[106]  M. Olschewski,et al.  Left atrial appendage flow velocity as a quantitative surrogate parameter for thromboembolic risk: determinants and relationship to spontaneous echocontrast and thrombus formation--a transesophageal echocardiographic study in 500 patients with cerebral ischemia. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[107]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[108]  P. Wenaweser,et al.  Transcatheter left atrial appendage closure in patients with atrial fibrillation. Comparison between non-dedicated and dedicated Amplatzer Devices , 2013 .

[109]  N. Ammash,et al.  Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographics tudy , 1995 .

[110]  S. Amorosi,et al.  The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[111]  D. Packer,et al.  The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial. , 2006, American heart journal.

[112]  Susan Regan,et al.  Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation , 2007, Circulation.

[113]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[114]  P. Raskin,et al.  Late breaking clinical trials 1 , 2011 .

[115]  J. Halperin,et al.  Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit. , 2012, European heart journal.

[116]  Bernhard Meier,et al.  Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[117]  R. Hart,et al.  Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 2000 .

[118]  H. Lee,et al.  Cardioembolic stroke: dual-energy cardiac CT for differentiation of left atrial appendage thrombus and circulatory stasis. , 2012, Radiology.

[119]  E. Sideris,et al.  Transcatheter patch occlusion of the left atrial appendage using surgical adhesives in high-risk patients with atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[120]  Susan B. Johnson,et al.  Percutaneous Epicardial Left Atrial Appendage Closure: Preliminary Results of an Electrogram Guided Approach , 2009, Journal of cardiovascular electrophysiology.